Skip to : [Content] [Navigation]
Medical Product Manufacturing News
 

Archive for March, 2009

Vesta Gets Extrumed

Tuesday, March 31st, 2009

Vesta Inc. (Franklin, WI), a support services company for the OEM medical device industry that provides silicone moldings, thermoplastic extruded tubing, assemblies, and secondary operations, has completed its acquisition of Extrumed LLC (Placentia, CA), the largest independent manufacturer of precision thermoplastic tubing for diagnostic and therapeutic medical devices and procedures.

The merger will create a market-leading contract manufacturer of precision thermoplastic and silicone tubing, silicone molding, and device assembly operations, according to Apur Lathiya, vice president of sales and marketing at Extrumed, a portfolio company of Inverness Graham Investments and Wedbush Capital Partners. In addition, the merger does not include plans to combine the manufacturing facilities of the two companies but will focus instead on sharing best practices to make each organization stronger. The merged firms, he notes, will produce more than 60 million medical device components annually.

“We are attracted to Extrumed’s capabilities in high-precision thermoplastic tubing extrusion and its strong reputation for quality and customer service,” says Joseph F. Damico, chairman of the board of Vesta and a founding partner of RoundTable Healthcare Partners, which holds a majority interest in Vesta. “Adding Extrumed’s capabilities in thermoplastics to Vesta’s core competencies in silicone-component manufacturing broadens the outsourcing capabilities we can provide to our customers.”

Extrumed CEO Bill Ellerkamp adds, “Vesta and RoundTable are ideal partners for Extrumed and its employees…. Vesta will be able to enhance our market position through their operational, sales, and marketing expertise as well as their relationships with medical device OEMs.”

Don’t Miss MPMN’s Webcast on Emerging Technologies Today!

Tuesday, March 31st, 2009

There’s still time to register for MPMN’s Webcast event, Emerging Technologies Showcase, sponsored by Gems Sensors & Controls. The live event will be held today, March 31, at 2 pm EST/ 11 am PST, and will bring to light several cutting-edge technologies that hold promise for drastically reshaping and improving medical device design and development down the road. Speakers include John Rogers of the University of Illinois, who will discuss stretchy, curvilinear electronics; Z.L. Wang, who will speak about harvesting biomechanical energy for powering implantable devices; and Roger Narayan, who will talk about his work with nanoporous materials and micro and nanostructures. Register now, or check in tomorrow to access the archive of the event.

MRIs Blast Off Into the Future

Friday, March 27th, 2009

Used to fuel space shuttles, parahydrogen may have found a new application in launching next-generation MRI technology.

Researchers from the University of York (UK) have developed a parahydrogen manipulation method that they have dubbed signal amplification by reversible exchange, or SABRE for short. The team’s technique entails transferring polarization from parahydrogen to a specially designed molecular scaffold substrate. The resulting molecules are seen easily by MRI and nuclear magnetic resonance technologies. In fact, the researchers demonstrated that they were able to increase MRI sensitivity by 1000 times. An expedited scanning process and reduced costs are also potential benefits of the technology.

In addition to enabling improved scanning, the technology could allow for increasing the range of conditions that are analyzed for diagnoses. This expanded capability lends itself to diagnosing such conditions as cancer and trauma.

“Our method has the potential to help doctors make faster and more-accurate diagnoses in a wide range of medical conditions,” says Gary Green, a professor in the department of psychology and director of the York Neuroimaging Centre. “The technique could ultimately replace current clinical imaging technologies that depend on the use of radioactive substances or heavy metals, which themselves create health concerns.”

The researchers are currently seeking partners to help them commercialize the technology. Videos of the technology can be found at the group’s Web site.

Blood Lust

Thursday, March 26th, 2009

Only about 7% of humans have O negative blood—the blood type that can be transfused into anyone without causing tissue rejection. The rarity of this blood type poses problems for blood transfusion services, which must rely on a steady-stream of donors to provide a constant supply of fresh blood. But help is on the way.

A three-year UK research project will develop the technology for producing unlimited amounts of synthetic human blood from embryonic stem cells. Supported by the National Health Services Blood and Transplant, the Scottish National Blood Transfusion Service, and the Wellcome Trust (the world’s largest charity devoted to medical research), researchers will test human embryos left over from in vitro fertilization treatments to single out those embryos that are genetically programmed to develop into O negative blood.

Scientists think that O negative blood can be produced in unlimited quantities from embryonic stem cells because the cells can be induced to multiply indefinitely in the laboratory. The aim of the UK project is to stimulate embryonic stem cells to develop into mature, oxygen-carrying red blood cells. In addition to being plentiful, synthetic blood will not be at risk of carrying infectious viruses such HIV and hepatitis.

An obvious boon to armies around the world that require large quantities of blood for wounded soldiers, the project will also benefit accident victims and those requiring blood transfusions during surgery. Thus, scientists in several other countries, including Sweden, France, and Australia, are developing similar projects to produce synthetic blood from embryonic stem cells.

Smart Products Opens East Coast Office

Wednesday, March 25th, 2009

Smart Products Inc. (Morgan Hill, CA), a supplier of valves and pumps used in medical devices, has opened a facility in Boone, NC. Having operated in California for 27 years, the expansion marks a new period of growth for the company, which offers more than 3 million mix-and-match valve configurations.

The new office will be home to a team of product application specialists who are trained to answer technical and compatibility-related questions regarding the company’s components. Situated in eastern North Carolina, the Boone facility enables the company to increase its accessiblity for customers located outside the Pacific time zone.

Available in standard and custom designs, the company’s valves are used to control the flow of fluid or gas in low-pressure, low-flow OEM systems. In addition to the valves, the supplier offers liquid and air pumps.

Mack Gets Energy-Efficient, Wins Award

Wednesday, March 25th, 2009
Mack Molding has installed 2100 high-intensity fluorescent light fixtures that eliminate hotspots and shadows on the production floor and will save enough energy to power 300 homes.

Mack Molding has installed 2100 high-intensity fluorescent light fixtures that eliminate hotspots and shadows on the production floor and will save enough energy to power 300 homes.

Contract manufacturing and molding services provider Mack Molding Co. (Arlington, VT) recently completed an energy-efficient lighting overhaul at three of its facilities. The company’s efforts have not only resulted in better use of electricity, but also won it a Progressive Manufacturing 100 award from Managing Automation Media (New York City).

Affecting a total of more than 600,000 sq ft of manufacturing space at the three plants, the $450,000 lighting project called for installing more than 2100 high-intensity fluorescent light fixtures. The new fixtures are expected to save more than 1.7 million kWh per year of electricity, which is enough electricity to power approximately 300 Vermont homes, or can be equated to taking 167 cars off the road, according to the company. In addition to the energy-efficiency gains, the new fixtures have increased light levels throughout the plants and eliminated hot spots and shadows.

The company, which provides custom injection molding and product-development services for various medical device manufacturing applications, will be presented with the award at a ceremony in Sarasota, FL, in June at Managing Automation’s Progressive Manufacturing Summit.

Scientists Cut Down Biofilm Buildup

Tuesday, March 24th, 2009

Biofilm formation on implants is a persistent problem in the medical community that can result in life-threatening infections. In recent years, this issue has garnered increasing attention from scientists and coating specialists as they work toward discovering a method for inhibiting bacterial growth on the devices. Researchers from Syracuse University (SU) are the latest to shed light on the sticky situation with their development of a novel material surface that has demonstrated the ability to repel bacteria.

To create the material, the researchers deposited a 20-nm-thick layer of gold onto a glass surface and then placed lab-generated molecules on top of the gold film. Through experiments with the material, the team discovered that mammalian cells and bacteria differ in their methods of adhesion to surfaces: mammalian cells require an anchor to stick to a surface while bacteria can attach to almost any sticky surface. Furthermore, the scientists gained insight into controlling bacterial growth on surfaces and were able to confine biofilm formation to designated 2-D patterns.

In addition to gaining insight about adhesion, the researchers found that this surface material was able to manipulate and confine biofilm four times longer than existing methods of inhibition. The scientists hope that these revelations can contribute to better implant design in the future. “This level of surface control has never before been achieved,” says Dacheng Ren, assistant professor of biomedical engineering at SU. “We hope that what we have learned in the laboratory will help answer other fundamental questions in surface materials research and lead to the production of new materials for use in medicine and industry.”

Bucks for Biotech

Monday, March 23rd, 2009

The North Carolina Biotechnology Center (Research Triangle Park, NC), has announced that it will grant $2.5 million over four years to establish the Center of Innovation, a program for fostering the growth of the state’s advanced medical technologies sector. The Biotechnology Center, a nonprofit state-supported institution, says that the new innovation center will be a team of people rather than a physical place. Its goal will be to reach out to hospitals, help inventors to gain access to sources of funding and business advice, and collaborate with economic development groups.

The center will complement North Carolina’s burgeoning medical technologies industry. According to J. Greg Davis, president and CEO of Tryton Medical (Durham, NC) and head of planning for the innovation center, “Our state’s strengths in biotechnology, information technology, regenerative medicine, medical devices, and other technological disciplines provides us with an ideal opportunity to promote future economic growth based on the convergence of existing medical technologies with these complementary innovation assets.”

Still on the prowl for a president to run the innovation center, The North Carolina Biotechnology Center says that it will seek matching grants for the program. Eventually, it hopes that the project will be funded through private donations, conference sponsorships, and other revenue sources.

Adhesive Technology Flexes Its Mussels

Friday, March 20th, 2009

Natural ‘glue’ produced by mussels that enables them to adhere to rocks has piqued the interest of researchers in recent years as a potential source of medical adhesive technology. Coupling the natural mussel protein adhesive with ink-jet technology has yielded the latest breakthrough in this area courtesy of a research team led by scientists at North Carolina State University (NC State; Raleigh).

The mussel glue could potentially obviate the need for synthetic adhesives, which can cause inflammation, tissue damage, or other such complications, according to the team. Nontoxic and biodegradable, the mussel proteins could be used to create custom medical adhesives with applications in postsurgical eye wound repair, fracture fixation, wound closure, and drug delivery, for example.

To develop these bioadhesives, the researchers employed piezoelectric ink-jet technology. “This is an improved way of joining tissues because the use of the ink-jet technology gives you greater control over the placement of the adhesive,” says Roger Narayan, associate professor in the joint biomedical engineering department of NC State and the University of North Carolina at Chapel Hill. “This helps ensure that the tissues are joined together in just the right spot, forming a better bond that leads to improved healing and less scarring.”

In addition to his work with mussels for medical applications, Narayan is also involved with the development of nanoporous membranes and biosensors. He will be speaking about such technologies and their potential medical applications in MPMN’s upcoming Webcast event: Emerging Technologies Showcase, sponsored by Gems Sensors & Controls. Along with Narayan, the Webcast will include presentations by Z.L. Wang of Georgia Tech, whose work was recently named by MIT Technolgy Review as one of 2009’s ‘10 technologies that can change the way we live,’ and John Rogers of the University of Illinois who is pioneering research in flexible, stretchable electronics for medical applications. Register for our March 31 Webcast event: Emerging Technologies Showcase now!

Energy Incentives Can Mean Money in Your Pocket

Thursday, March 19th, 2009

The federal government, state governments, and utility companies offer incentives to business owners to encourage them to purchase energy-efficient machinery. The incentives are designed to offset the cost of such machinery, which can be higher than less-efficient models. “But thousands of dollars [in incentives] go by the wayside because people don’t know about them,” said Bruce Blau of Bruce Blau & Associates (Fresno, CA), an energy consulting firm. Blau spoke about incentives on Tuesday at Engel North America’s (York, PA) ribbon-cutting ceremony for its technical center in Corona, CA. Engel supplies injection-molding equipment, including a line of all-electric, energy-efficient machines.

Incentives differ from rebates in that companies must apply for them before removing old equipment and buying or installing new energy-efficient equipment, according to Blau, whose firm offers services to help companies through the incentive filing and inspection process. Incentives are calculated based on several parameters, such as throughput, run time, and the type of machine that is purchased. In California, for example, fixed-volume hydraulic machines are used as the industry standard to measure against. The state’s incentives for variable-volume equipment run from 8 to 13% of machine costs; all-electric models can qualify for more, according to Blau. Funding for incentives comes from a fee collected from every energy user in the state.

Part of the incentive-filing process includes pre- and postinstallation inspections at a company’s facility. Blau suggested that this is where having a consultant on your side can really make a difference. There have been instances in which inspectors measured the wrong throughput products, he said. His firm offers to coordinate inspection appointments and accompany the inspector so that the inspector doesn’t inadvertently come up with lower run times and throughputs. Blau’s firm then reviews the approved incentive to make sure the correct amount is paid. The process takes about four to six weeks, he said.

Resources for learning more about incentives in your area can be found online or by contacting your state energy office, local utilities, or consulting firms like Blau’s. One such online resource is the Database of State Incentives for Renewables & Efficiency (DSIRE), an ongoing project of the North Carolina Solar Center (Raleigh, NC) and the Interstate Renewable Energy Council (Latham, NY) funded by the U.S. Department of Energy (Washington, DC). The DSIRE Web site allows visitors to search for incentives by state, type, technology, and eligible sectors.